Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 445 to 454 of 454 entries
Sorted by: Best Match Show Resources per page
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster.

bioRxiv : the preprint server for biology

Lusvarghi S, Pollett SD, Neerukonda SN, Wang W, Wang R, Vassell R, Epsi NJ, Fries AC, Agan BK, Lindholm DA, Colombo CJ, Mody R, Ewers EC, Lalani T, Ganesan A, Goguet E, Hollis-Perry M, Coggins SAA, Simons MP, Katzelnick LC, Wang G, Tribble DR, Bentley L, Eakin AE, Broder CC, Erlandson KJ, Laing ED, Burgess TH, Mitre E, Weiss CD.
PMID: 34981057
bioRxiv. 2021 Dec 28; doi: 10.1101/2021.12.22.473880.

The rapid spread of the highly contagious Omicron variant of SARS-CoV-2 along with its high number of mutations in the spike gene has raised alarm about the effectiveness of current medical countermeasures. To address this concern, we measured neutralizing...

Cite
Lusvarghi S, Pollett SD, Neerukonda SN, et al. SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster. bioRxiv. 2021;doi: 10.1101/2021.12.22.473880.
Lusvarghi, S., Pollett, S. D., Neerukonda, S. N., Wang, W., Wang, R., Vassell, R., Epsi, N. J., Fries, A. C., Agan, B. K., Lindholm, D. A., Colombo, C. J., Mody, R., Ewers, E. C., Lalani, T., Ganesan, A., Goguet, E., Hollis-Perry, M., Coggins, S. A. A., Simons, M. P., Katzelnick, L. C., Wang, G., Tribble, D. R., Bentley, L., Eakin, A. E., Broder, C. C., Erlandson, K. J., Laing, E. D., Burgess, T. H., Mitre, E., & Weiss, C. D. (2021). SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.12.22.473880
Lusvarghi, Sabrina, et al. "SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.12.22.473880
Lusvarghi S, Pollett SD, Neerukonda SN, Wang W, Wang R, Vassell R, Epsi NJ, Fries AC, Agan BK, Lindholm DA, Colombo CJ, Mody R, Ewers EC, Lalani T, Ganesan A, Goguet E, Hollis-Perry M, Coggins SAA, Simons MP, Katzelnick LC, Wang G, Tribble DR, Bentley L, Eakin AE, Broder CC, Erlandson KJ, Laing ED, Burgess TH, Mitre E, Weiss CD. SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster. bioRxiv. 2021 Dec 28; doi: 10.1101/2021.12.22.473880. PMID: 34981057; PMCID: PMC8722594.
Copy Download .nbib Format: NLM
Correction to: Surgical treatment of colonic Crohn's disease: a national snapshot study.

Langenbeck's archives of surgery

, Celentano V, Pellino G, Rottoli M, Poggioli G, Sica G, Giglio MC, Campanelli M, Coco C, Rizzo G, Sionne F, Colombo F, Sampietro G, Lamperti G, Foschi D, Ficari F, Vacca L, Cricchio M, Giudici F, Selvaggi L, Sciaudone G, Peltrini R, Manfreda A, Bucci L, Galleano R, Ghazouani O, Zorcolo L, Deidda S, Restivo A, Braini A, Di Candido F, Sacchi M, Carvello M, Martorana S, Bordignon G, Angriman I, Variola A, Barugola G, Di Ruscio M, Tanzanu M, Geccherle A, Tropeano FP, Luglio G, Sasia D, Migliore M, Giuffrida MC, Marrano E, Moretto G, Impellizzeri H, Gallo G, Vescio G, Sammarco G, Terrosu G, Calini G, Bondurri A, Maffioli A, Zaffaroni G, Resegotti A, Mistrangelo M, Allaix ME, Botti F, Prati M, Boni L, Perotti S, Mineccia M, Giuliani A, Romano L, Graziano GMP, Pugliese L, Pietrabissa A, Delaini G, Spinelli A, Selvaggi F.
PMID: 33651161
Langenbecks Arch Surg. 2021 Mar 02; doi: 10.1007/s00423-021-02119-7. Epub 2021 Mar 02.

No abstract available.

Cite
, Celentano V, Pellino G, et al. Correction to: Surgical treatment of colonic Crohn's disease: a national snapshot study. Langenbecks Arch Surg. 2021;doi: 10.1007/s00423-021-02119-7.
, Celentano, V., Pellino, G., Rottoli, M., Poggioli, G., Sica, G., Giglio, M. C., Campanelli, M., Coco, C., Rizzo, G., Sionne, F., Colombo, F., Sampietro, G., Lamperti, G., Foschi, D., Ficari, F., Vacca, L., Cricchio, M., Giudici, F., Selvaggi, L., Sciaudone, G., Peltrini, R., Manfreda, A., Bucci, L., Galleano, R., Ghazouani, O., Zorcolo, L., Deidda, S., Restivo, A., Braini, A., Di Candido, F., Sacchi, M., Carvello, M., Martorana, S., Bordignon, G., Angriman, I., Variola, A., Barugola, G., Di Ruscio, M., Tanzanu, M., Geccherle, A., Tropeano, F. P., Luglio, G., Sasia, D., Migliore, M., Giuffrida, M. C., Marrano, E., Moretto, G., Impellizzeri, H., Gallo, G., Vescio, G., Sammarco, G., Terrosu, G., Calini, G., Bondurri, A., Maffioli, A., Zaffaroni, G., Resegotti, A., Mistrangelo, M., Allaix, M. E., Botti, F., Prati, M., Boni, L., Perotti, S., Mineccia, M., Giuliani, A., Romano, L., Graziano, G. M. P., Pugliese, L., Pietrabissa, A., Delaini, G., Spinelli, A., & Selvaggi, F. (2021). Correction to: Surgical treatment of colonic Crohn's disease: a national snapshot study. Langenbeck's archives of surgery, . https://doi.org/10.1007/s00423-021-02119-7
, et al. "Correction to: Surgical treatment of colonic Crohn's disease: a national snapshot study." Langenbeck's archives of surgery vol. (2021). doi: https://doi.org/10.1007/s00423-021-02119-7
, Celentano V, Pellino G, Rottoli M, Poggioli G, Sica G, Giglio MC, Campanelli M, Coco C, Rizzo G, Sionne F, Colombo F, Sampietro G, Lamperti G, Foschi D, Ficari F, Vacca L, Cricchio M, Giudici F, Selvaggi L, Sciaudone G, Peltrini R, Manfreda A, Bucci L, Galleano R, Ghazouani O, Zorcolo L, Deidda S, Restivo A, Braini A, Di Candido F, Sacchi M, Carvello M, Martorana S, Bordignon G, Angriman I, Variola A, Barugola G, Di Ruscio M, Tanzanu M, Geccherle A, Tropeano FP, Luglio G, Sasia D, Migliore M, Giuffrida MC, Marrano E, Moretto G, Impellizzeri H, Gallo G, Vescio G, Sammarco G, Terrosu G, Calini G, Bondurri A, Maffioli A, Zaffaroni G, Resegotti A, Mistrangelo M, Allaix ME, Botti F, Prati M, Boni L, Perotti S, Mineccia M, Giuliani A, Romano L, Graziano GMP, Pugliese L, Pietrabissa A, Delaini G, Spinelli A, Selvaggi F. Correction to: Surgical treatment of colonic Crohn's disease: a national snapshot study. Langenbecks Arch Surg. 2021 Mar 02; doi: 10.1007/s00423-021-02119-7. Epub 2021 Mar 02. PMID: 33651161.
Copy Download .nbib Format: NLM
Single-cell profiling defines the prognostic benefit of CD39.

Communications biology

Losurdo A, Scirgolea C, Alvisi G, Brummelman J, Errico V, Di Tommaso L, Pilipow K, Colombo FS, Fernandes B, Peano C, Testori A, Tinterri C, Roncalli M, Santoro A, Mazza EMC, Lugli E.
PMID: 34552178
Commun Biol. 2021 Sep 22;4(1):1117. doi: 10.1038/s42003-021-02595-z.

Luminal-like breast cancer (BC) constitutes the majority of BC subtypes, but, differently from highly aggressive triple negative BC, is poorly infiltrated by the immune system. The quality of the immune infiltrate in luminal-like BCs has been poorly studied, thereby...

Cite
Losurdo A, Scirgolea C, Alvisi G, et al. Single-cell profiling defines the prognostic benefit of CD39. Commun Biol. 2021;4(1):1117doi: 10.1038/s42003-021-02595-z.
Losurdo, A., Scirgolea, C., Alvisi, G., Brummelman, J., Errico, V., Di Tommaso, L., Pilipow, K., Colombo, F. S., Fernandes, B., Peano, C., Testori, A., Tinterri, C., Roncalli, M., Santoro, A., Mazza, E. M. C., & Lugli, E. (2021). Single-cell profiling defines the prognostic benefit of CD39. Communications biology, 4(1), 1117. https://doi.org/10.1038/s42003-021-02595-z
Losurdo, Agnese, et al. "Single-cell profiling defines the prognostic benefit of CD39." Communications biology vol. 4,1 (2021): 1117. doi: https://doi.org/10.1038/s42003-021-02595-z
Losurdo A, Scirgolea C, Alvisi G, Brummelman J, Errico V, Di Tommaso L, Pilipow K, Colombo FS, Fernandes B, Peano C, Testori A, Tinterri C, Roncalli M, Santoro A, Mazza EMC, Lugli E. Single-cell profiling defines the prognostic benefit of CD39. Commun Biol. 2021 Sep 22;4(1):1117. doi: 10.1038/s42003-021-02595-z. PMID: 34552178; PMCID: PMC8458450.
Copy Download .nbib Format: NLM
Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Elia E, Iannaccone M, D'Ascenzo F, Gallone G, Colombo F, Albani S, Attisani M, Rinaldi M, Boccuzzi G, Conrotto F, Noussan P, De Ferrari GM.
PMID: 34028964
Catheter Cardiovasc Interv. 2022 Jan 01;99(1):27-36. doi: 10.1002/ccd.29757. Epub 2021 May 24.

OBJECTIVE: Aim of this study is to evaluate short term safety and efficacy of Impella in high risk percutaneous coronary intervention (HR-PCI) population.BACKGROUND: While several studies demonstrated the clinical significance of Impella in HR-PCI, few data exist about its...

Cite
Elia E, Iannaccone M, D'Ascenzo F, et al. Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2021;99(1):27-36doi: 10.1002/ccd.29757.
Elia, E., Iannaccone, M., D'Ascenzo, F., Gallone, G., Colombo, F., Albani, S., Attisani, M., Rinaldi, M., Boccuzzi, G., Conrotto, F., Noussan, P., & De Ferrari, G. M. (2022). Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 99(1), 27-36. https://doi.org/10.1002/ccd.29757
Elia, Edoardo, et al. "Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 99,1 (2022): 27-36. doi: https://doi.org/10.1002/ccd.29757
Elia E, Iannaccone M, D'Ascenzo F, Gallone G, Colombo F, Albani S, Attisani M, Rinaldi M, Boccuzzi G, Conrotto F, Noussan P, De Ferrari GM. Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2022 Jan 01;99(1):27-36. doi: 10.1002/ccd.29757. Epub 2021 May 24. PMID: 34028964.
Copy Download .nbib Format: NLM
H.

Journal of advanced research

Corvino A, Citi V, Fiorino F, Frecentese F, Magli E, Perissutti E, Santagada V, Calderone V, Martelli A, Gorica E, Brogi S, Colombo FF, Capello CN, Araujo Ferreira HH, Rimoli MG, Sodano F, Rolando B, Pavese F, Petti A, Muscará MN, Caliendo G, Severino B.
PMID: 35024201
J Adv Res. 2021 May 20;35:267-277. doi: 10.1016/j.jare.2021.05.008. eCollection 2022 Jan.

INTRODUCTION: Hydrogen sulfide (HOBJECTIVES: We herein describe the design and synthesis of molecular hybrids obtained by the condensation of several corticosteroids with different hydrogen sulfide releasing moieties.METHODS: All the molecules are characterized for their ability to release HRESULTS: Prednisone-TBZ...

Cite
Corvino A, Citi V, Fiorino F, et al. H. J Adv Res. 2021;35:267-277doi: 10.1016/j.jare.2021.05.008.
Corvino, A., Citi, V., Fiorino, F., Frecentese, F., Magli, E., Perissutti, E., Santagada, V., Calderone, V., Martelli, A., Gorica, E., Brogi, S., Colombo, F. F., Capello, C. N., Araujo Ferreira, H. H., Rimoli, M. G., Sodano, F., Rolando, B., Pavese, F., Petti, A., Muscará, M. N., Caliendo, G., & Severino, B. (2022). H. Journal of advanced research, 35267-277. https://doi.org/10.1016/j.jare.2021.05.008
Corvino, Angela, et al. "H." Journal of advanced research vol. 35 (2022): 267-277. doi: https://doi.org/10.1016/j.jare.2021.05.008
Corvino A, Citi V, Fiorino F, Frecentese F, Magli E, Perissutti E, Santagada V, Calderone V, Martelli A, Gorica E, Brogi S, Colombo FF, Capello CN, Araujo Ferreira HH, Rimoli MG, Sodano F, Rolando B, Pavese F, Petti A, Muscará MN, Caliendo G, Severino B. H. J Adv Res. 2021 May 20;35:267-277. doi: 10.1016/j.jare.2021.05.008. eCollection 2022 Jan. PMID: 35024201; PMCID: PMC8721254.
Copy Download .nbib Format: NLM
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019.

Open forum infectious diseases

Richard SA, Epsi NJ, Pollett S, Lindholm DA, Malloy AMW, Maves R, Utz GC, Lalani T, Smith AG, Mody RM, Ganesan A, Colombo RE, Colombo CJ, Chi SW, Huprikar N, Larson DT, Bazan S, Madar C, Lanteri C, Rozman JS, English C, Mende K, Tribble DR, Agan BK, Burgess TH, Powers JH.
PMID: 34901299
Open Forum Infect Dis. 2021 Oct 08;8(12):ofab517. doi: 10.1093/ofid/ofab517. eCollection 2021 Dec.

BACKGROUND: The inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) is a patient-reported outcome data collection instrument assessing symptoms of viral respiratory tract infections across 8 body systems. This study evaluated the measurement properties of FLU-PRO Plus in a study enrolling...

Cite
Richard SA, Epsi NJ, Pollett S, et al. Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2021;8(12):ofab517doi: 10.1093/ofid/ofab517.
Richard, S. A., Epsi, N. J., Pollett, S., Lindholm, D. A., Malloy, A. M. W., Maves, R., Utz, G. C., Lalani, T., Smith, A. G., Mody, R. M., Ganesan, A., Colombo, R. E., Colombo, C. J., Chi, S. W., Huprikar, N., Larson, D. T., Bazan, S., Madar, C., Lanteri, C., Rozman, J. S., English, C., Mende, K., Tribble, D. R., Agan, B. K., Burgess, T. H., Powers, J. H. (2021). Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019. Open forum infectious diseases, 8(12), ofab517. https://doi.org/10.1093/ofid/ofab517
Richard, Stephanie A, et al. "Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019." Open forum infectious diseases vol. 8,12 (2021): ofab517. doi: https://doi.org/10.1093/ofid/ofab517
Richard SA, Epsi NJ, Pollett S, Lindholm DA, Malloy AMW, Maves R, Utz GC, Lalani T, Smith AG, Mody RM, Ganesan A, Colombo RE, Colombo CJ, Chi SW, Huprikar N, Larson DT, Bazan S, Madar C, Lanteri C, Rozman JS, English C, Mende K, Tribble DR, Agan BK, Burgess TH, Powers JH. Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2021 Oct 08;8(12):ofab517. doi: 10.1093/ofid/ofab517. eCollection 2021 Dec. PMID: 34901299; PMCID: PMC8661080.
Copy Download .nbib Format: NLM
Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer.

The Journal of experimental medicine

Masetti M, Carriero R, Portale F, Marelli G, Morina N, Pandini M, Iovino M, Partini B, Erreni M, Ponzetta A, Magrini E, Colombo P, Elefante G, Colombo FS, den Haan JMM, Peano C, Cibella J, Termanini A, Kunderfranco P, Brummelman J, Chung MWH, Lazzeri M, Hurle R, Casale P, Lugli E, DePinho RA, Mukhopadhyay S, Gordon S, Di Mitri D.
PMID: 34919143
J Exp Med. 2022 Feb 07;219(2). doi: 10.1084/jem.20210564. Epub 2021 Dec 17.

Tumor-associated macrophages (TAMs) are correlated with the progression of prostatic adenocarcinoma (PCa). The mechanistic basis of this correlation and therapeutic strategies to target TAMs in PCa remain poorly defined. Here, single-cell RNA sequencing was used to profile the transcriptional...

Cite
Masetti M, Carriero R, Portale F, et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med. 2021;219(2)doi: 10.1084/jem.20210564.
Masetti, M., Carriero, R., Portale, F., Marelli, G., Morina, N., Pandini, M., Iovino, M., Partini, B., Erreni, M., Ponzetta, A., Magrini, E., Colombo, P., Elefante, G., Colombo, F. S., den Haan, J. M. M., Peano, C., Cibella, J., Termanini, A., Kunderfranco, P., Brummelman, J., Chung, M. W. H., Lazzeri, M., Hurle, R., Casale, P., Lugli, E., DePinho, R. A., Mukhopadhyay, S., Gordon, S., & Di Mitri, D. (2022). Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. The Journal of experimental medicine, 219(2), . https://doi.org/10.1084/jem.20210564
Masetti, Michela, et al. "Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer." The Journal of experimental medicine vol. 219,2 (2022). doi: https://doi.org/10.1084/jem.20210564
Masetti M, Carriero R, Portale F, Marelli G, Morina N, Pandini M, Iovino M, Partini B, Erreni M, Ponzetta A, Magrini E, Colombo P, Elefante G, Colombo FS, den Haan JMM, Peano C, Cibella J, Termanini A, Kunderfranco P, Brummelman J, Chung MWH, Lazzeri M, Hurle R, Casale P, Lugli E, DePinho RA, Mukhopadhyay S, Gordon S, Di Mitri D. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med. 2022 Feb 07;219(2). doi: 10.1084/jem.20210564. Epub 2021 Dec 17. PMID: 34919143.
Copy Download .nbib Format: NLM
Postoperative complications and waiting time for surgical intervention after radiologically guided drainage of intra-abdominal abscess in patients with Crohn's disease.

BJS open

El-Hussuna A, Karer MLM, Uldall Nielsen NN, Mujukian A, Fleshner PR, Iesalnieks I, Horesh N, Kopylov U, Jacoby H, Al-Qaisi HM, Colombo F, Sampietro GM, Marino MV, Ellebæk M, Steenholdt C, Sørensen N, Celentano V, Ladwa N, Warusavitarne J, Pellino G, Zeb A, Di Candido F, Hurtado-Pardo L, Frasson M, Kunovsky L, Yalcinkaya A, Tatar OC, Alonso S, Pera M, Granero AG, Rodríguez CA, Minaya A, Spinelli A, Qvist N.
PMID: 34518869
BJS Open. 2021 Sep 06;5(5). doi: 10.1093/bjsopen/zrab075.

BACKGROUND: In patients with active Crohn's disease (CD), treatment of intra-abdominal abscess usually comprises antibiotics and radiologically guided percutaneous drainage (PD) preceding surgery. The aim of this study was to investigate the risk of postoperative complications and identify the...

Cite
El-Hussuna A, Karer MLM, Uldall Nielsen NN, et al. Postoperative complications and waiting time for surgical intervention after radiologically guided drainage of intra-abdominal abscess in patients with Crohn's disease. BJS Open. 2021;5(5)doi: 10.1093/bjsopen/zrab075.
El-Hussuna, A., Karer, M. L. M., Uldall Nielsen, N. N., Mujukian, A., Fleshner, P. R., Iesalnieks, I., Horesh, N., Kopylov, U., Jacoby, H., Al-Qaisi, H. M., Colombo, F., Sampietro, G. M., Marino, M. V., Ellebæk, M., Steenholdt, C., Sørensen, N., Celentano, V., Ladwa, N., Warusavitarne, J., Pellino, G., Zeb, A., Di Candido, F., Hurtado-Pardo, L., Frasson, M., Kunovsky, L., Yalcinkaya, A., Tatar, O. C., Alonso, S., Pera, M., Granero, A. G., Rodríguez, C. A., Minaya, A., Spinelli, A., & Qvist, N. (2021). Postoperative complications and waiting time for surgical intervention after radiologically guided drainage of intra-abdominal abscess in patients with Crohn's disease. BJS open, 5(5), . https://doi.org/10.1093/bjsopen/zrab075
El-Hussuna, A, et al. "Postoperative complications and waiting time for surgical intervention after radiologically guided drainage of intra-abdominal abscess in patients with Crohn's disease." BJS open vol. 5,5 (2021). doi: https://doi.org/10.1093/bjsopen/zrab075
El-Hussuna A, Karer MLM, Uldall Nielsen NN, Mujukian A, Fleshner PR, Iesalnieks I, Horesh N, Kopylov U, Jacoby H, Al-Qaisi HM, Colombo F, Sampietro GM, Marino MV, Ellebæk M, Steenholdt C, Sørensen N, Celentano V, Ladwa N, Warusavitarne J, Pellino G, Zeb A, Di Candido F, Hurtado-Pardo L, Frasson M, Kunovsky L, Yalcinkaya A, Tatar OC, Alonso S, Pera M, Granero AG, Rodríguez CA, Minaya A, Spinelli A, Qvist N. Postoperative complications and waiting time for surgical intervention after radiologically guided drainage of intra-abdominal abscess in patients with Crohn's disease. BJS Open. 2021 Sep 06;5(5). doi: 10.1093/bjsopen/zrab075. PMID: 34518869; PMCID: PMC8438259.
Copy Download .nbib Format: NLM
Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients.

Frontiers in cardiovascular medicine

Myasoedova VA, Genovese S, Cavallotti L, Bonomi A, Chiesa M, Campodonico J, Rondinelli M, Cosentino N, Baldassarre D, Veglia F, Pepi M, Alamanni F, Colombo GI, Marenzi G, Poggio P.
PMID: 34386534
Front Cardiovasc Med. 2021 Jul 27;8:711899. doi: 10.3389/fcvm.2021.711899. eCollection 2021.

No abstract available.

Cite
Myasoedova VA, Genovese S, Cavallotti L, et al. Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients. Front Cardiovasc Med. 2021;8:711899doi: 10.3389/fcvm.2021.711899.
Myasoedova, V. A., Genovese, S., Cavallotti, L., Bonomi, A., Chiesa, M., Campodonico, J., Rondinelli, M., Cosentino, N., Baldassarre, D., Veglia, F., Pepi, M., Alamanni, F., Colombo, G. I., Marenzi, G., & Poggio, P. (2021). Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients. Frontiers in cardiovascular medicine, 8711899. https://doi.org/10.3389/fcvm.2021.711899
Myasoedova, Veronika A, et al. "Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients." Frontiers in cardiovascular medicine vol. 8 (2021): 711899. doi: https://doi.org/10.3389/fcvm.2021.711899
Myasoedova VA, Genovese S, Cavallotti L, Bonomi A, Chiesa M, Campodonico J, Rondinelli M, Cosentino N, Baldassarre D, Veglia F, Pepi M, Alamanni F, Colombo GI, Marenzi G, Poggio P. Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients. Front Cardiovasc Med. 2021 Jul 27;8:711899. doi: 10.3389/fcvm.2021.711899. eCollection 2021. PMID: 34386534; PMCID: PMC8354333.
Copy Download .nbib Format: NLM
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.

The Journal of infectious diseases

Lu Z, Laing ED, Pena DaMata J, Pohida K, Tso MS, Samuels EC, Epsi NJ, Dorjbal B, Lake C, Richard SA, Maves RC, Lindholm DA, Rozman JS, English C, Huprikar N, Mende K, Colombo RE, Colombo CJ, Broder CC, Ganesan A, Lanteri CA, Agan BK, Tribble D, Simons MP, Dalgard CL, Blair PW, Chenoweth J, Pollett SD, Snow AL, Burgess TH, Malloy AMW.
PMID: 34673956
J Infect Dis. 2021 Dec 15;224(12):2010-2019. doi: 10.1093/infdis/jiab543.

BACKGROUND: Characterizing the longevity and quality of cellular immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enhances understanding of coronavirus disease 2019 (COVID-19) immunity that influences clinical outcomes. Prior studies suggest SARS-CoV-2-specific T cells are present in...

Cite
Lu Z, Laing ED, Pena DaMata J, et al. Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection. J Infect Dis. 2021;224(12):2010-2019doi: 10.1093/infdis/jiab543.
Lu, Z., Laing, E. D., Pena DaMata, J., Pohida, K., Tso, M. S., Samuels, E. C., Epsi, N. J., Dorjbal, B., Lake, C., Richard, S. A., Maves, R. C., Lindholm, D. A., Rozman, J. S., English, C., Huprikar, N., Mende, K., Colombo, R. E., Colombo, C. J., Broder, C. C., Ganesan, A., Lanteri, C. A., Agan, B. K., Tribble, D., Simons, M. P., Dalgard, C. L., Blair, P. W., Chenoweth, J., Pollett, S. D., Snow, A. L., Burgess, T. H., Malloy, A. M. W. (2021). Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection. The Journal of infectious diseases, 224(12), 2010-2019. https://doi.org/10.1093/infdis/jiab543
Lu, Zhongyan, et al. "Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection." The Journal of infectious diseases vol. 224,12 (2021): 2010-2019. doi: https://doi.org/10.1093/infdis/jiab543
Lu Z, Laing ED, Pena DaMata J, Pohida K, Tso MS, Samuels EC, Epsi NJ, Dorjbal B, Lake C, Richard SA, Maves RC, Lindholm DA, Rozman JS, English C, Huprikar N, Mende K, Colombo RE, Colombo CJ, Broder CC, Ganesan A, Lanteri CA, Agan BK, Tribble D, Simons MP, Dalgard CL, Blair PW, Chenoweth J, Pollett SD, Snow AL, Burgess TH, Malloy AMW. Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection. J Infect Dis. 2021 Dec 15;224(12):2010-2019. doi: 10.1093/infdis/jiab543. PMID: 34673956.
Copy Download .nbib Format: NLM
Showing 445 to 454 of 454 entries